Market Herald logo

Subscribe

Be the first with the news that moves the market
  • ResApp Health (RAP) has received nearly $2 million from its research and development (R&D) tax incentive
  • CEO Tony Keating is grateful for the Federal Government’s continued support of R&D by Australian companies
  • ResApp is down 2.04 per cent on the market today and is trading at 24¢ apiece

ResApp Health (RAP) has received $1.8 million from its research and development (R&D) tax incentive.

The Australian Federal Government’s R&D tax incentive program provides a cash refund on eligible research and development activities performed by Australian companies.

ResApp is a leading digital health company developing smartphone applications for the diagnosis and management of respiratory diseases. It uses machine learning algorithms that detect sound and thereby discover respiratory illnesses.

CEO Tony Keating is grateful for the Federal Government’s continued support of R&D by Australian companies.

“Over the past four years, the program has helped us invest in the continued development of our audio-based machine learning algorithms, resulting in the world’s first clinical-validated and regulatory approved smartphone application for acute respiratory diagnosis,” Tony said.

“This year’s rebate further strengthens our balance sheet and allows us to continue to invest resources and accelerate commercialisation,” he added.

Recently, ResApp entered an agreement with Coviu to integrate its respiratory app into the company’s telehealth software program.

ResApp is down 2.04 per cent on the market today and is trading at 24¢ apiece at 12:34 pm AEDT.

RAP by the numbers
More From The Market Herald

" Appen (ASX:APX) positioned to weather pandemic, reaffirms guidance

Data annotation and artificial intelligence company Appen (ASX:APX) has today reaffirmed its guidance for the 2020…

" Appen (ASX:APX) sailing through COVID-19 storm unaffected

Appen (ASX:APX) has reaffirmed its yearly financial guidance and expects only a negligible impact from the…

" Appen (ASX:APX) downgrades earnings guidance as growth stutters

Machine learning and AI specialist Appen (ASX:APX) has downgraded its 2020 earnings guidance due to the…

" MSL Solutions (ASX:MSL) wins Stadiums Queensland contract

Sports, leisure and hospitality SaaS technology provider MSL Solutions (ASX:MSL) has signed a five-year contract with…